CD8A and breast cancer: In mouse orthotopic breast cancer models HSV1716 inhibited tumor growth and metastases after intravenous administration, which was associated with increased activated CD8+ T cells, decreased Tregs, and the reprogramming of tumor-associated macrophages (TAMs) to a pro-inflammatory M1-like phenotype [45].